Clinical patterns of metastasis

Cancer and Metastasis Reviews

Volumn 25, Issue 2, 2006, Pages 221-232

  Leong, Stanley P L ^a   Cady, Blake ^b   Jablons, David M ^a   Garcia Aguilar, Julio ^a   Reintgen, Douglas ^c   Jakub, J ^c   Pendas, S ^c   Duhaime, L ^c   Cassell, R ^c   Gardner, M ^c   Giuliano, R ^c   Archie, V ^c   Calvin, D ^c   Mensha, L ^c   Shivers, S ^c   Cox, C ^d   Werner, J A ^e   Kitagawa, Y ^f   Kitajima, M ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c Lakeland Regional Cancer Center   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Cancer metastasis; Lymphovascular system; Sentinel lymph nodes

Indexed keywords

ANTINEOPLASTIC AGENT; COLLOID TC 99M; PROTEIN TYROSINE KINASE INHIBITOR; RADIOPHARMACEUTICAL AGENT; TRACER; TRYPAN BLUE;

BIOLOGY; BONE MARROW METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER LOCALIZATION; CELL HETEROGENEITY; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS RESECTION; GASTRECTOMY; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; MELANOMA; METASTASIS; MICROMETASTASIS; MOLECULAR CLONING; NECK DISSECTION; NONHUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SARCOMA; SENTINEL LYMPH NODE; SOLID TUMOR; STOMACH ADENOCARCINOMA; THYROID PAPILLARY CARCINOMA;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM METASTASIS; SARCOMA; SENTINEL LYMPH NODE BIOPSY; THYROID NEOPLASMS;

EID: 33745168981     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-8502-8     Document Type: Conference Paper

References (119)

1. Gervasoni JE, Jr., Taneja C, Chung MA, Cady B: Biologic and clinical significance of lymphadenectomy. Surg Clin North Am 80(6): 1631-1673, 2000
2. Zurrida S, Orecchia R, Galimberti V, et al.: Axillary radiotherapy instead of axillary dissection: A randomized trial. Italian Oncological Senology Group. Ann Surg Oncol 9(2): 156-160, 2002
3. Louis-Sylvestre C, Clough K, Asselain B, et al.: Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22(1): 97-101, 2004
4. Naik AM, Fey J, Gemignani M, et al.: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 240(3): 462-468, 2004; discussion 468-471.
5. Coburn NG, Chung MA, Fulton J, Cady B: Decreased breast cancer tumor size, stage, and mortality in rhode island: An example of a well-screened population. Cancer Control 11(4): 222-230, 2004
6. Heimann R, Munsell M, McBride R: Mammographically detected breast cancers and the risk of axillary lymph node involvement: Is it just the tumor size? Cancer J 8(3): 276-281, 2002
7. Norden T, Thurfjell E, Hasselgren M, et al.: Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer 33(4): 624-628, 1997
8. Bucchi L, Barchielli A, Ravaioli A, et al.: Screen-detected vs clinical breast cancer: The advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 92(1): 156-161, 2005
9. Cote R, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM: Role of immunohistochemical detection of lymph node metastases in management of breast cancer. International Breast Cancer Study Group Lancet 354(9182): 896-900, 1999
10. Hellman S: The natural history of small breast cancers: The David A. Karnovsky Memorial Lecture. J Clin Oncol 12: 2229-2234, 1994
11. Halsted WS.: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46: 1-9, 1907
12. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361(9367): 1405-1410, 2003
13. Cady B.: Presidential address: Beyond risk groups - a new look at differentiated thyroid cancer. Surgery 124(6): 947-957, 1998
14. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4): 934-59, 2003
15. Mullen JT, Wang H, Yao JC, et al.: Carcinoid tumors of the duodenum. Surgery 138(6): 971-978, 2005
16. Balch CM, AC B, Soong S, Atkins MB, Cascinelli N, et al.: Final version of the american joint committee on cancer staging system for cutaneous melanoma. Journal of Clinical Oncology 19(16): 3635-3648, 2001
17. Reintgen DS, Cruse CW, Wells K, et al.: The orderly progression of melanoma nodal metastases. Ann Surg 220: 759-767, 1994
18. Allen PJ, Coit DG: The surgical management of metastatic melanoma. Ann Surg Oncol 9(8): 762-770, 2002
19. Patel JK, Didolkar MS, Pickren JW, Moore RH: Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135(6): 807-810, 1978
20. AJCC: Cancer Staging Manual, 6 ed. New York: Springer, 2003. (Page DL, Fleming ID, Fritz AG, et al., eds.)
21. Leong SPL: Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience. Ann Surg Oncol 11(3 Suppl): 192S-197S, 2004
22. Leong SPL: Sentinel lymph node mapping and selective lymphadenectomy: The standard of care for melanoma. Current Treatment Options in Oncology 5(3): 185-194, 2004
23. Leong SP, Kashani-Sabet M, Desmond RA, et al.: Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg 29(6): 683-691, 2005
24. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, Wanek LA, Glass E, Foshag LJ, Hsueh EC, Bilchik AJ, Elashoff D, Elashoff R: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238(4): 538-549, 2003; discussion 549-550.
25. Reintgen D, Balch CM, Kirkwood J, Ross M: Recent advances in the care of the patient with malignant melanoma. Ann Surg 225(1): 1-14, 1997
26. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276(22): 1818-1822, 1996
27. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer - A multicenter validation study. N Engl J Med 339(14): 941-946, 1998
28. Wilke L, McCall L, Posther K, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE 2nd, Giuliano AE: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 13(4): 491-500, 2006.
29. Reintgen D, Giuliano R, Cox C: Lymphatic mapping and sentinel lymph node biopsy for breast cancer. Cancer J 8(Suppl 1): S15-S21, 2002
30. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14(6): 1868-1876, 1996
31. Fisch UP: Cervical Lymphography in Cases of Laryngo-Pharyngeal Carcinoma. J Laryngol Otol 78: 715-726, 1964
32. Fisch UP: Lymphographische untersuchung uber das zervikale. Lymphsystem 1966; Karger(Basel)
33. Schwab W, Winkel Kz: [The current status of scintigraphy of the cervical lymphatic system]. Nucl Med (Stuttg) 6(2): 234-249, 1967
34. Zita G: [Contribution on cervical lymphoscintigraphy]. Fortschr Geb Rontgenstr Nuklearmed 107(5): 644-654, 1967
35. Michailov V, Mlatschkov C: [Evaluation of cervical lymph node scintigraphy]. Radiobiol Radiother (Berl) 10(6): 769-777, 1969
36. Lindberg R: Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29(6): 1446-1449, 1972
37. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, Wolf GT; American Head and Neck Society; American Academy of Otolaryngology-Head and Neck Surgery: Neck dissection classification update: Revisions proposed by the American head and neck society and the American academy of Otolaryngology-head and neck surgery. Arch Otolaryngol Head Neck Surg 128(7): 751-758, 2002
38. Hosal AS, Carrau RL, Johnson JT, Myers EN: Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope 110(12): 2037-2040, 2000
39. van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA, Snow GB: The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106(8): 987-991 1996
40. Teichgraeber JF, Clairmont AA: The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: Treatment rationale. Head Neck Surg 7(1): 15-21, 1984
41. Gavilan J, Gavilan C, Herranz J: The neck in supraglottic cancer. In: Smee R, Bridger G, (Hrsg.) (eds.) Laryngeal cancer. Elsevier, Amsterdam, pp. 576-581, 1994
42. DeSanto LW, Magrina C, O'Fallon WM: The "second" side of the neck in supraglottic cancer. Otolaryngol Head Neck Surg 102(4): 351-361, 1990
43. Godden DR, Ribeiro NF, Hassanein K, Langten SG: Recurrent neck disease in oral cancer. J Oral Maxillolac Surg 60(7): 748-753, 2002; discussion753-755.
44. Werner J, Davis R: Metastasis in Head and Neck Cancer: Springer, Heidelberg, in press.
45. Werner J, Dunne A, Brandt D, et al.: Untersuchungen zum stellenwert der sentinel lymphonodektomie bei Karzinomen des pharynx und Larynx. Laryngohinootologie 78: 663-670, 1999
46. Werner JA: Selective sentinel Lymphadenectomy for head and neck squamous cell carcinoma. In: Leong S, Kitagawa Y, Kitajima M (eds.) Selective Sentinel Lymphadenectomy for Human Solid Cancer. Springer 2004
47. Dunne AA, Jungclas H, Werner JA: Intraoperative sentinel node biopsy in patients with squamous cell carcinomas of the head and neck - Experiences using a well-type NaI detector for gamma ray spectroscopy. Otolaryngol Pol 55(2): 127-134, 2001
48. Croce A, Bianchedi M, Moretti A, Minni A: [The surgical treatment of laterocervical adenopathies due to malignant cervicofacial tumors]. G Chir 13(11-12): 553-556, 1992
49. Coatesworth AP, MacLennan K: Squamous cell carcinoma of the upper aerodigestive tract: The prevalence of microscopic extracapsular spread and soft tissue deposits in the clinically NO neck. Head Neck 24(3): 258-261, 2002
50. Beger HG, Schwarz A, Bergmann U: Progress in gastrointestinal tract surgery: The impact of gastrointestinal endoscopy. Surg Endosc 17(2): 342-350, 2003
51. Liu Y, Zhang X: [Analysis of complications about gynecologic endoscopic procedures in 14 hospitals of Shanghai during 1992-2001]. Zhonghua Fu Chan Ke Za Zhi 37(11): 646-649, 2002
52. Einarsson JI, Young A, Tsien L, Sangi-Haghpeykar H: Perceived proficiency in endoscopic techniques among senior obstetrics and gynecology residents. J Am Assoc Gynecol Laparosc 9(2): 158-64, 2002
53. Werner JA, Sapundzhiev NR, Teymoortash A, Dunne AA, Behr T, Folz BJ: Endoscopic sentinel lymphadenectomy as a new diagnostic approach in the NO neck. Eur Arch Otorhinolaryngol 261(9): 463-468, 2004
54. Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, Saito H, Kita I, Takashima S: Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today 29(8): 695-700, 1999
55. Matsubara T, Ueda M, Kaisaki S, Kuroda J, Uchida C, Kokudo N, Takahashi T, Nakajima T, Yanagisawa A: Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer 89(9): 1869-1873, 2000
56. Sano T, Katai H, Sasako M, et al.: Gastric lymphadenectomy and detection of sentinel nodes. Recent Results Cancer Res 157: 253-258, 2000
57. Akiyama H, Tsuramaru M, Udagawa H, Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220(3): 364-372, 1994; discussion 372-373.
58. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T: Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210(5): 596-602, 1989
59. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H; Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12): 908-914, 1999
60. Hulscher J, van Sandick J, de Boer A, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Eng J Med 347: 1662-1669, 2002
61. Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Watanabe M, Ohgami M, Otani Y, Ozawa S, Hasegawa H, Furukawa T, Kumai K, Ikeda T, Nakahara T, Kubo A, Kitajima M: The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 80(6): 1799-809, 2000
62. Hiratsuka M, Miyashiro I, Ishikawa O, Furukawa H, Motomura K, Ohigashi H, Kameyama M, Sasaki Y, Kabuto T, Ishiguro S, Imaoka S, Koyama H: Application of sentinel node biopsy to gastric cancer surgery. Surgery 129(3): 335-340, 2001
63. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M: Radio-guided sentinel node detection for gastric cancer. Br J Surg 89(5): 604-608, 2002
64. Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A: Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90(2): 178-182, 2003
65. Kitagawa Y, Kitano S, Kubota T, Kumai K, Otani Y, Saikawa Y, Yoshida M, Kitajima M: Minimally invasive surgery for gastric cancer - Toward a confluence of two major streams: A review. Gastric Cancer 8(2): 103-110, 2005
66. Feith M, Stein HJ, Siewert JR: Pattern of lymphatic spread of Barren's cancer. World J Surg 27(9): 1052-1057, 2003
67. Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, Toh Y, Fujii T, Tou U, Shirouzu K: Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21(3): 275-281, 1997
68. Mafune KI, Tanaka Y, Takubo K: Autopsy findings in patients with esophageal carcinoma: Comparison between resection and nonresection groups. J Surg Oncol 74(3): 196-200, 2000
69. Yuasa N, Miyake H, Yamada T, Oda K, Nimura Y, Nagasaka T, Hattori T: Prognostic significance of the location of intramural metastasis in patients with esophageal squamous cell carcinoma. Langenbecks Arch Surg 389(2): 122-127, 2004
70. Saito T, Iizuka T, Kato H, Watanabe H: Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer 56(9): 2235-2241, 1985
71. Kato H, Miyazaki T, Nakajima M, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H: Prediction of hematogenous recurrence in patients with esophageal carcinoma. Jpn J Thorac Cardiovasc Surg 51(11): 599-608, 2003
72. Yamagata K, Kumagai K, Shimizu K, Masuo K, Nishida Y, Yasui A: Gastrointestinal cancer metastasis and lymphogenous spread: Viewpoint of animal models of lymphatic obstruction. Jpn J Clin Oncol 28(2): 104-106, 1998
73. Kumagai K, Tanaka T, Yamagata K, Yokoyama N, Shimizu K: Liver metastasis in gastric cancer with particular reference to lymphatic advancement. Gastric Cancer 4(3): 150-155, 2001
74. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240(5): 808-816, 2004
75. Sano T, Sasako M, Kinoshita T, Maruyama K: Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 72(11): 3174-3178, 1993
76. Niederhuber JE: Colon and rectum cancer. Patterns of spread and implications for workup. Cancer 71(12 Suppl): 4187-4192, 1993
77. Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K: The extent of lymph node dissection for colon carcinoma: The potential impact on laparoscopic surgery. Cancer 80(2): 188-192, 1997
78. Hirokazu Y, Sawai K, Taniguchi H: Analysis of vascular anatomy and lymph node metastasis warrants radical segmental bowel resection for colon cancer. World J Surg 21: 109-115, 1997
79. Grinnell R: The lymphatic and venous spread of carcinoma of the rectum. Cancer Supplement 116: 200-216, 1942
80. Steup WH, Moriya Y, van de Velde CJ: Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 38(7): 911-918, 2002
81. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 69(10): 613-616, 1982
82. Wang Z, Zhou ZG, Wang C, Zhao GP, Chen YD, Gao HK, Zheng XL, Wang R, Chen DY, Liu WP: Microscopic spread of low rectal cancer in regions of mesorectum: Pathologic assessment with whole-mount sections. World J Gastroenterol 10(20): 2949-2953, 2004
83. Koh DM, Brown G, Temple L, Blake H, Raja A, Toomey P, Bett N, Farhat S, Norman AR, Daniels I, Husband JE: Distribution of mesorectal lymph nodes in rectal cancer: In vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol 15(8): 1650-1657, 2005
84. Hida J, Yasutomi M, Fujimoto K, Maruyama T, Okuno K, Shindo K: Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. Cancer Supplement 184: 475-480, 1997
85. Thorn C, Woodcock N, Scott N, Verbeke C, Scott SB, Ambrose NS: What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 6: 356-361, 2004
86. Pheby DF, Levine DF, Pitcher RW, Shepherd NA: Lymph node harvests directly influence the staging of colorectal cancer: Evidence from a regional audit. J Clin Pathol 57(1): 43-47, 2004
87. Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, Smith AJ: Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol 84(3): 120-126, 2003
88. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol 21(15): 2912-2919, 2003
89. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22(10): 1785-1796, 2004
90. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA: Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 97(3): 219-225, 2005
91. Weiss L, Grandmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoglio-Preiser CM, Napier J, Horne CHW, Lopez MJ, Shwo-Dunn RI, Sugar J, Davies JD, Day DW, Harlos JP: Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 150(3): 195-203, 1986
92. Wigmore SJ, Madhavan K, Redhead DN, Currie EJ, Garden OJ: Distribution of colorectal liver metastases in patients referred for hepatic resection. Cancer 89(2): 285-287, 2000
93. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19): 1407-1427, 2005
94. Henschke CI, Shaham D, Yankelevitz DF, Altorki NK: CT screening for lung cancer: Past and ongoing studies. Semin Thorac Cardiovasc Surg 17(2): 99-106, 2005
95. Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ: Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: Final results of the Toronto phase II trial. Lung Cancer 47(1): 103-109, 2005
96. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13(8): 1880-1892, 1995
97. McKenna RJ, Jr., Houck W, Fuller CB: Video-assisted thoracic surgery lobectomy: Experience with 1,100 cases. Ann Thorac Surg 81(2): 421-425, 2006; discussion 425-426.
98. Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H: Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: Priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 27(11): 1598-1609, 2000
99. Liptay MJ: Sentinel lymph node mapping in lung cancer. Cancer Treat Res 127: 141-150, 2005
100. Minamiya Y, Ogawa J: The current status of sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Cardiovasc Surg 11(2): 67-72, 2005
101. Tiffet O, Nicholson AG, Khaddage A, Prevot N, Ladas G, Dubois F, Goldstraw P: Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest 127(2): 443-448, 2005
102. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K: In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissection. Lung Cancer 46(1): 49-55, 2004
103. Faries MB, Bleicher RJ, Ye X, Essner R, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg 139(8): 870-876, 2004; discussion 876-877.
104. Irjala H, Alanen K, Grenman R, Heikkila P, Joensuu H, Jalkanen S: Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 63(15): 4671-4676, 2003
105. Taneja C, Cady B: Decreasing role of lymphatic system surgery in surgical oncology. J Surg Oncol 89(2): 61-66, 2005
106. Cady B: Is axillary lymph node dissection necessary in routine management of breast cancer? No. Principles and Practice of Oncology. No. Principles and Practice of Oncology 12:1-12, 12: 1-12, 1998
107. Fisher B, Fisher ER: Transmigration of lymph nodes by tumor cells. Science 152(727): 1397-1398, 1966
108. Huang RR, Wen DR, Guo J, Giuliano AE, Nguyen M, Offodile R, Stern S, Turner R, Cochran AJ: Selective modulation of paracortical dendritic cells and T-lymphocytes in breast cancer sentinel lymph nodes. Breast J 6(4): 225-232, 2000
109. Tang Y, Zhang D, Fallavollita L, Brodt P: Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res 63(6): 1166-1171, 2003
110. LeBedis C, Chen K, Fallavollita L, Boutros T, Brodt P: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002 100: 2-8, 2002
111. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7(2): 192-198, 2001
112. Espana L, Fernandez Y, Rubio N, Torregrosa A, Blanco J, Sierra A: Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 87(1): 33-44, 2004
113. Brodt P, Fallavollita L, Khatib AM, Samani AA, Zhang D: Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit. J Biol Chem 276(36): 33608-33615, 2001
114. Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P: Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62(19): 5393-5398, 2002
115. Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS: Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 9(15): 5532-5539, 2003
116. Fong Y, Coit DG, Woodruff JM, Brennan MF: Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217(1): 72-77, 1993
117. Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, Brennan MF: Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of diseases and postmetastasis survival. Ann Surg 229(5): 602-610; discussion 610-612, 1999
118. Helman LJ, Meltzer P: Mechanisms of sarcoma development. Nat Rev Cancer 3(9): 685-694, 2003
119. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21(23): 4342-4349, 2003